Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies ; volume:5 ; number:1 ; day:1 ; month:3 ; year:2016 ; pages:45-57 ; date:6.2016
Neurology and Therapy ; 5, Heft 1 (1.3.2016), 45-57, 6.2016
- Urheber
-
Gold, Ralf
- Beteiligte Personen und Organisationen
-
Giovannoni, Gavin
Phillips, J. Theodore
Fox, Robert J.
Zhang, Annie
Marantz, Jing L.
SpringerLink (Online service)
- DOI
-
10.1007/s40120-016-0042-8
- URN
-
urn:nbn:de:1111-201606258033
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gold, Ralf
- Giovannoni, Gavin
- Phillips, J. Theodore
- Fox, Robert J.
- Zhang, Annie
- Marantz, Jing L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relapsing/remitting type 1 diabetes
Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis